☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
lumakras
PharmaShots Interview: Guardant Health's Justin Odegaard Shares Insight on the US FDA's Approval of Guardant360 CDx for Amgen's Lu...
July 29, 2021
Amgen’s Lumakras (sotorasib) Receives MHLW Approval for the Treatment of Advanced Non-Small Cell Lung Cancer
January 20, 2022
BridgeBio and Amgen Entered into a Non-Exclusive Clinical Collaboration for BBP-398 in P-I/II Study for Advanced Solid Tumors
January 14, 2022
PharmaShots Interview: Guardant Health's Justin Odegaard Shares Insight on the US FDA's Approval of Guardant360 CDx for Amgen's Lu...
July 29, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.